Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation.

Diabetes research and clinical practice - 1 May 2016

Khelifa Souhaïra Ben, Dendana Azza, Barboura Ilhem, Khochtali Ines, Chahed Hinda, Ferchichi Selima, Miled Abdelhedi

Abstract excerpt

The hot spot mutation P291fsinsC was identified for the first time in a 26 years old Tunisian woman. The low serum level of high C-reactive protein was helpful to target the HNF1A gene. Due to the molecular diagnosis, the change from insulin to sulfonylurea therapy was performed successfully.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Diabetes Mellitus, Type 2
Share to Hepatocyte Nuclear Factor 1-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Injections, Intramuscular

Share to Insulin

Share to Sulfonylurea Compounds

Share to Tunisia

Source

Identifiers

PMID: 26822262
DOI: 10.1016/j.diabres.2016.01.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation.PMID 26822262Read ↗

A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metforminSemantic proximity Read ↗

Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea.Semantic proximity Read ↗

Treatment of young patients with HNF1A mutations (HNF1A-MODY).Semantic proximity Read ↗

Effect of mutation at c.493T>C locus of transcription factor HNF1α gene on its protein level.Semantic proximity Read ↗

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201Semantic proximity Read ↗

[HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes].Semantic proximity Read ↗

A novel nonsense mutation of the HNF1α in maturity-onset diabetes of the young type 3 in Asian population.Semantic proximity Read ↗

Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.Semantic proximity Read ↗

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.Semantic proximity Read ↗

Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approachSemantic proximity Read ↗

Clinical heterogeneity of abnormal glucose homeostasis associated with the HNF4A R311H mutation.Semantic proximity Read ↗

A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.